Biotech 2050 Podcast

Stephanie Sirota, CBO & Partner at RTW Investments, on Biotech Investing, Policy & Bold Bet Building


Listen Later

Synopsis:
What happens when a former journalist becomes one of biotech’s boldest investors? Meet Stephanie Sirota, Chief Business Officer and Partner at RTW Investments, who helped grow the firm from $27 million in assets to a global biotech force. In this engaging conversation with host Rahul Chaturvedi, Stephanie shares her unconventional path into the industry, and how a mission-driven, science-led investment strategy has guided RTW’s approach across public markets, private deals, and company creation.
Stephanie reflects on the evolution of biotech financing, why GLP-1 drugs are just getting started, and how RTW is preparing for changes in U.S. healthcare policy. She also unpacks how the firm sources opportunities, evaluates risk, and sticks to long-term conviction even in volatile markets. For Stephanie, great biotech investing starts with deep research, strong science, and a relentless focus on patient outcomes.
Whether you're an investor, operator, or simply curious about the future of medicine, this conversation is packed with insights on building bold bets—and the staying power behind them.
Biography:
Stephanie leads a team at RTW overseeing business development, strategic partnerships, communications, and investor relations.
Her background in investment banking and expertise in financial markets has helped position the firm as both a partner to life sciences companies and a steward of investors’ capital. Stephanie also manages RTW’s relationships with key partners including banks, academic institutions, corporations, investors, and NGOs. She has led the firm’s entry into the UK and European markets and serves as a director of the RTW Biotech Opportunities Ltd, a publicly traded investment fund listed on the London Stock Exchange.
Prior to joining RTW, she served as director at Valhalla Capital Advisors, a macro and commodity investment manager. Stephanie also worked in the New York and London offices of Lehman Brothers, where she advised on various Merger & Acquisitions, IPOs, and capital market financing transactions with a focus on cross-border transactions for the firm’s global corporate clients.
Stephanie graduated with honors from Columbia University and also received a Master’s Degree from the Columbia Graduate School of Journalism.
She serves as president of the RTW Foundation; and co-chair of Council of the New York Philharmonic.
...more
View all episodesView all episodes
Download on the App Store

Biotech 2050 PodcastBy Biotech 2050

  • 4.7
  • 4.7
  • 4.7
  • 4.7
  • 4.7

4.7

59 ratings


More shows like Biotech 2050 Podcast

View all
Making Sense with Sam Harris by Sam Harris

Making Sense with Sam Harris

26,332 Listeners

The Bio Report by Levine Media Group

The Bio Report

39 Listeners

The Daily by The New York Times

The Daily

110,865 Listeners

Up First from NPR by NPR

Up First from NPR

55,866 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

124 Listeners

The Readout Loud by STAT

The Readout Loud

318 Listeners

The Prof G Pod with Scott Galloway by Vox Media Podcast Network

The Prof G Pod with Scott Galloway

5,249 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

88 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

31 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

146 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

15,294 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

11 Listeners

Cell & Gene: The Podcast by Erin Harris

Cell & Gene: The Podcast

38 Listeners

Beyond Biotech - the podcast from Labiotech by Labiotech

Beyond Biotech - the podcast from Labiotech

3 Listeners

The BioCentury Show by BioCentury

The BioCentury Show

11 Listeners